These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7617147)

  • 21. Relationship between extracellular 5-hydroxytryptamine and behaviour following monoamine oxidase inhibition and L-tryptophan.
    Sleight AJ; Marsden CA; Martin KF; Palfreyman MG
    Br J Pharmacol; 1988 Feb; 93(2):303-10. PubMed ID: 2451963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The maturational onset of the 5-HT mediated head twitch in mice.
    Eble JP; Goodrich C
    Physiol Behav; 1987; 41(1):47-51. PubMed ID: 3500481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential effects of coadministration of fluoxetine and WAY-100635 on serotonergic neurotransmission in vivo: sensitivity to sequence of injections.
    Taber MT; Kinney GG; Pieschl RL; Yocca FD; Gribkoff VK
    Synapse; 2000 Oct; 38(1):17-26. PubMed ID: 10941137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serotonergic involvement in phencyclidine-induced behaviors.
    Nabeshima T; Yamaguchi K; Hiramatsu M; Amano M; Furukawa H; Kameyama T
    Pharmacol Biochem Behav; 1984 Sep; 21(3):401-8. PubMed ID: 6208563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of indirectly acting 5-HT receptor agonists on circulating melatonin levels in rats.
    Huether G; Poeggeler B; Adler L; Rüther E
    Eur J Pharmacol; 1993 Jul; 238(2-3):249-54. PubMed ID: 8405095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tryptophan supplementation and serotonin function: genetic variations in behavioural effects.
    Gibson EL
    Proc Nutr Soc; 2018 May; 77(2):174-188. PubMed ID: 29368666
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 5-Hydroxytryptamine-mediated behaviour in male and female rats.
    Dickinson SL; Curzon G
    Neuropharmacology; 1986 Jul; 25(7):771-6. PubMed ID: 3748324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Substituted piperazine and indole compounds increase extracellular serotonin in rat diencephalon as determined by in vivo microdialysis.
    Auerbach SB; Rutter JJ; Juliano PJ
    Neuropharmacology; 1991 Apr; 30(4):307-11. PubMed ID: 1852265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutic effects of in vivo administration of an inhibitor of tryptophan 2,3-dioxygenase (680c91) for the treatment of fibroids: a preclinical study.
    Chuang TD; Ton N; Rysling S; Quintanilla D; Boos D; Khorram O
    Fertil Steril; 2024 Apr; 121(4):669-678. PubMed ID: 38072367
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5-HT4 receptor-mediated modulation of 5-HT release in the rat hippocampus in vivo.
    Ge J; Barnes NM
    Br J Pharmacol; 1996 Apr; 117(7):1475-80. PubMed ID: 8730742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The serotonergic antidepressant nefazodone inhibits the serotonin transporter: in vivo and ex vivo studies.
    Owens MJ; Ieni JR; Knight DL; Winders K; Nemeroff CB
    Life Sci; 1995; 57(24):PL373-80. PubMed ID: 7475971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolism of 6-fluoro-DL-tryptophan and its specific effects on the rat brain serotoninergic pathway.
    Chanut E; Trouvin JH; Bondoux D; Gardier A; Launay JM; Jacquot C
    Biochem Pharmacol; 1993 Mar; 45(5):1049-57. PubMed ID: 7681671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Indoleamine-2,3-Dioxygenase/Kynurenine Pathway as a Potential Pharmacological Target to Treat Depression Associated with Diabetes.
    da Silva Dias IC; Carabelli B; Ishii DK; de Morais H; de Carvalho MC; Rizzo de Souza LE; Zanata SM; Brandão ML; Cunha TM; Ferraz AC; Cunha JM; Zanoveli JM
    Mol Neurobiol; 2016 Dec; 53(10):6997-7009. PubMed ID: 26671617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of Ca2+ antagonists and hydralazine on central 5-hydroxytryptamine biochemistry and function in rats and mice.
    Green AR; DeSouza RJ; Davies EM; Cross AJ
    Br J Pharmacol; 1990 Jan; 99(1):41-6. PubMed ID: 1691944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ketamine treatment involves medial prefrontal cortex serotonin to induce a rapid antidepressant-like activity in BALB/cJ mice.
    Pham TH; Mendez-David I; Defaix C; Guiard BP; Tritschler L; David DJ; Gardier AM
    Neuropharmacology; 2017 Jan; 112(Pt A):198-209. PubMed ID: 27211253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 5-Hydroxytryptamine: the effects of impaired synthesis on its metabolism and release in rat.
    Curzon G; Fernando JC; Marsden CA
    Br J Pharmacol; 1978 Aug; 63(4):627-34. PubMed ID: 80243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serotonergic manipulations both potentiate and reduce brain stimulation reward in rats: involvement of serotonin-1A receptors.
    Harrison AA; Markou A
    J Pharmacol Exp Ther; 2001 Apr; 297(1):316-25. PubMed ID: 11259559
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serotonin1B receptor activation mimics behavioral effects of presynaptic serotonin release.
    Rempel NL; Callaway CW; Geyer MA
    Neuropsychopharmacology; 1993 May; 8(3):201-11. PubMed ID: 8099482
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Somatodendritic autoreceptor regulation of serotonergic neurons: dependence on L-tryptophan and tryptophan hydroxylase-activating kinases.
    Liu RJ; Lambe EK; Aghajanian GK
    Eur J Neurosci; 2005 Feb; 21(4):945-58. PubMed ID: 15787701
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of acute treatment with YM992 on extracellular serotonin levels in the rat frontal cortex.
    Hatanaka K; Yatsugi S; Yamaguchi T
    Eur J Pharmacol; 2000 Apr; 395(1):23-9. PubMed ID: 10781669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.